Form 4: Olaplex Director Christine Dagousset Reports Acquisition and Disposal of Common Stock

Christine Dagousset, a director at Olaplex Holdings, Inc., reported the acquisition and disposal of common stock on August 8, 2024, according to a Form 4 filing with the SEC.

Summary

• On August 8, 2024, Christine Dagousset, a director of Olaplex Holdings, Inc., filed a Form 4 with the SEC.
• The filing reports the acquisition of 76,142 shares of common stock at $0 and the disposal of an unspecified number of shares.
• Following the reported transactions, Dagousset beneficially owns 144,189 shares of Olaplex common stock.
• The acquired shares represent restricted stock units (RSUs) granted under the company's 2021 Equity Incentive Plan, which will vest on July 16, 2025, contingent upon continued service.
• Dagousset also granted a Limited Power of Attorney to John Duffy, Tracie Chesterman, and Dorothy Hill, effective July 16, 2024, to handle SEC filings related to Olaplex securities.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing, indicating standard corporate governance practices. The RSU grant is a positive sign of aligning director interests with company performance, but it's not a major event.

Positives

• The RSU grant to a director aligns their interests with the long-term performance of the company.
• The continued service requirement for vesting incentivizes the director's ongoing commitment to Olaplex.

Future Outlook

The director's RSUs will vest on July 16, 2025, contingent upon continued service to the company.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

• RSU grants are a common form of executive compensation in publicly traded companies, aligning management's interests with shareholder value.
• The vesting schedule of the RSUs is typical, incentivizing long-term commitment from the director.

Stakeholder Impact

• The RSU grant aligns the director's interests with shareholders, potentially encouraging decisions that benefit the company's long-term value.
• The vesting schedule incentivizes the director's continued service, which can benefit employees and other stakeholders.

Key Dates